Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / January / Amyloid Glaucoma Links
Glaucoma Research & Innovations News

Amyloid-β & Glaucoma Links

Aβ in the Aqueous: a new clue in the glaucoma puzzle

1/13/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Top Institutions in Ophthalmology and Neurodegenerative Disease Research

Leading institutions combine clinical ophthalmology expertise with neurodegenerative disease research, utilizing advanced molecular biology, biomarker analysis, and imaging techniques to investigate amyloid-β's role in glaucomatous neurodegeneration and its correlation with retinal nerve fiber layer thinning.

  • #1

    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Massachusetts Eye and Ear is a world leader in glaucoma research and has extensive programs integrating neurodegenerative disease mechanisms with ocular pathology, including amyloid-β biomarker studies.

    Key Differentiators

    • Ophthalmology
    • Neurodegenerative Disease Research
  • #2

    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Wilmer Eye Institute is renowned for pioneering research on glaucoma pathophysiology and has active programs studying amyloid-β and other neurodegenerative markers in ocular tissues.

    Key Differentiators

    • Ophthalmology
    • Neuroscience
  • #3

    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Bascom Palmer is a top-ranked ophthalmology center with a strong focus on glaucoma and neurodegenerative mechanisms, including studies on amyloid-β accumulation in ocular tissues.

    Key Differentiators

    • Ophthalmology
    • Neuro-ophthalmology
  • #4

    National Eye Institute (NEI), NIH

    Bethesda, MD

    NEI funds and conducts cutting-edge research on glaucoma and Alzheimer's disease, supporting studies on amyloid-β's role in ocular neurodegeneration and biomarker development.

    Key Differentiators

    • Ophthalmology Research
    • Neurodegeneration
  • #5

    Ohashi Eye Center

    Tokyo, Tokyo Prefecture

    Known for pioneering clinical studies on amyloid-β in aqueous humor and its correlation with glaucoma severity, contributing valuable data on molecular links between glaucoma and Alzheimer's disease.

    Key Differentiators

    • Ophthalmology
    • Glaucoma Research

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: